Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Group B Streptococcus capsular polysaccharide antigen is an essential virulence determinant composed of diverse carbohydrate structures capped with sialic acids. It enables immune evasion through molecular mimicry while serving as both an epidemiological marker (serotyping) and primary target for vaccine development due to its surface exposure and ability to elicit protective antibody responses when presented appropriately to the immune system.
Induction of neutralizing antibodies, opsonization, complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Group B Streptococcus Capsular Polysaccharide Antigen (GBS CPS Antigen).